M&A Deal Summary |
|
|---|---|
| Date | 2004-12-10 |
| Target | Definity Health |
| Sector | Insurance |
| Buyer(s) | UnitedHealth |
| Sellers(s) | Alta Partners |
| Deal Type | Add-on Acquisition |
| Deal Value | 300M USD |
SEARCH BY
Try For Free 7-Day Free Trial
| Category | Company |
|---|---|
| Founded | 1974 |
| Sector | Healthcare Services |
| Employees | 440,000 |
| Revenue | 371.6B USD (2023) |
UnitedHealth is a diversified healthcare company. With a suite of health benefits and services, the company serves millions of individuals, employers, and government organizations. UnitedHealth operates through two primary businesses: UnitedHealthcare, which offers a range of health insurance plans and services, and Optum, which provides healthcare solutions focused on improving healthcare delivery, affordability, and outcomes. Through its network of healthcare providers, advanced analytics, and technology-driven solutions, UnitedHealth looks to make healthcare more accessible, efficient, and patient-centered, ultimately transforming the way healthcare is delivered and experienced. UnitedHealth was formed in 1974 and is based in Minnetonka, Minnesota.
| DEAL STATS | # |
|---|---|
| Overall | 5 of 16 |
| Sector (Insurance) | 4 of 7 |
| Type (Add-on Acquisition) | 5 of 12 |
| State (Minnesota) | 1 of 1 |
| Country (United States) | 5 of 14 |
| Year (2004) | 3 of 3 |
| Size (of disclosed) | 10 of 10 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2004-04-26 |
Oxford Health Plans
Trumbull, Connecticut, United States Oxford Health Plans, Inc. provides health plans to employers and individuals primarily in New York, New Jersey and Connecticut, through its direct sales force, independent insurance agents and brokers. Oxford's commercial insured products and services include traditional health maintenance organizations, preferred and exclusive provider organizations, point-of-service plans and consumer-directed health plans. The Company also offers Medicare plans and third-party administration of employer-funded benefits plans. |
Buy | $4.9B |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2005-07-06 |
PacifiCare Health Systems
Cypress, California, United States PacifiCare Health Systems is one of the US's largest consumer health organizations with nearly 3.2 million health plan members and approximately 11.3 million specialty plan members nationwide. PacifiCare offers individuals, employers and Medicare beneficiaries a variety of consumer-driven health care and life insurance products. Specialty plan operations include behavioral health, dental and vision, and complete pharmacy benefit management through its wholly owned subsidiary, Prescription Solutions. |
Buy | $8.1B |
| Category | Venture Capital Firm |
|---|---|
| Founded | 1996 |
| PE ASSETS | 2.6B USD |
| Size | Large |
| Type | Sector Focused |
Alta Partners is a venture capital firm that targets investments in early and later stage life science companies, including biopharmaceuticals, medical technology, and information technology businesses. Alta was formed as an early stage investor but has since expanded its investment range to provide later stage growth capital to private and young public companies. Alta was established in 1996 and is headquartered in San Francisco, California.
| DEAL STATS | # |
|---|---|
| Overall | 18 of 84 |
| Sector (Insurance) | 1 of 1 |
| Type (Add-on Acquisition) | 11 of 45 |
| State (Minnesota) | 2 of 4 |
| Country (United States) | 17 of 74 |
| Year (2004) | 5 of 6 |
| Size (of disclosed) | 13 of 23 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2004-11-01 |
Kerberos Proximal Solutions
Cupertino, California, United States Kerberos Proximal Solutions is a privately-held company focused on the development of innovative medical devices for the removal of thrombus, or blood clots, from occluded arteries. |
Buy | $11M |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2004-12-21 |
ILEX Oncology
San Antonio, Texas, United States ILEX Oncology, Inc. is a drug development company focused exclusively on the accelerated development of drugs for the treatment and prevention of cancer. ILEX Oncology was founded in 1992 and is based in San Antonio, Texas. |
Sell | $1.0B |
